We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Recent Development and Future Aspects: Nano-Based Drug Delivery System in Cancer Therapy.
- Authors
Rajendran, Sasireka; Ravi, Sai Nandhini; Nair, Vaishnavi M.; Sree, R. Pooja; Packirisamy, Azhagu Saravana Babu; Palanivelu, Jeyanthi
- Abstract
The rapid advancement of nanotechnology in the production of nanomedicine agents holds enormous promise for improving cancer therapy techniques. Nanomedicine products offer the possibility of developing complex targeting approaches as well as multifunctionality. Nanotechnology has been examined for the detection of extracellular cancer biomarkers and cancer cells, as well as in vivo imaging, sensitive and selective, accuracy, and multiplexed detection capacity. In fact, nanoparticles have the potential to not only address the limitations of traditional cancer diagnosis and treatment, but also to open up entirely new possibilities and develop cutting-edge technology for tumour detection and treatment. Nano carriers are used to increase target tumour cell specificity and delivery capability to the tumour site, enhancing therapy efficacy while reducing unwanted side effects. Nanocarriers that respond to exogenous or endogenous stimuli have emerged as a promising alternative to target drug delivery. In this review intervention of nanoparticle system for cancer types like Lung cancer, Breast cancer, Melanoma, Colorectal cancer, Bladder cancer are discussed. Further focused on the advancement of nanocarriers for cancer diagnosis and treatment. The critical review takes deeper insight on nanocarrier-based cancer therapy.
- Subjects
DRUG delivery systems; CANCER treatment; TUMOR markers; BLADDER cancer; NANOPARTICLES; LUNG cancer
- Publication
Topics in Catalysis, 2024, Vol 67, Issue 1-4, p203
- ISSN
1022-5528
- Publication type
Article
- DOI
10.1007/s11244-023-01893-6